PER-016-02已完成未知
Multicenter, open-label study to evaluate the safety ofTrlleptal® in patients with neuropathic pain due to diabeticneuropathy
OVARTIS BIOSCIENSES PERU S.A.,0 个研究点目标入组 0 人开始时间: 2002年2月21日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients will be ambulatory, men or women 18 years of age or older.
- •Patients must have an established diagnosis of diabetes mellitus (type I or II).
- •Patients must have had neuropathic pain due to diabetic neuropathy for at least 6 months.
- •Hemoglobin Aic levels must be 11% or lower.
- •Serum sodium levels should be at least 135mmoI / L.
排除标准
- •Patients with a clinically significant psychiatric diagnosis that may impede their reliable participation in the study.
- •Patients with known or suspected chronic infectious diseases including HIV, hepatitis B, or hepatitis C.
- •Patients with epilepsy.
- •Patients with an ECG with significant abnormalities ..
- •Patients with a history of renal failure documented by creatinine clearance <30 mL / min.
研究者
相似试验
进行中（未招募）
不适用
Contrast-Enhanced MRI of the supra-aortic vesselsSubjects with known or suspected vascular disease of the supra-aortic vesselsMedDRA version: 16.0Level: PTClassification code 10007687Term: Carotid artery stenosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2010-023001-36-SEBayer Health Care AG398
进行中（未招募）
不适用
Contrast-Enhanced MRI of the supra-aortic vesselsEUCTR2010-023001-36-DEBayer Health Care AG398
进行中（未招募）
不适用
Contrast-Enhanced MRI of the supra-aortic vesselsSubjects with known or suspected vascular disease of the supra-aortic vesselsMedDRA version: 16.0Level: PTClassification code 10007687Term: Carotid artery stenosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2010-023001-36-CZBayer Health Care AG398
进行中（未招募）
不适用
Contrast-Enhanced MRI of the renal arteriesEUCTR2010-023002-13-DEBayer HealthCare AG336
进行中（未招募）
1 期
Contrast-Enhanced MRI of the supra-aortic vesselsEUCTR2010-023001-36-FRBayer Health Care AG479